Comment & Analysis

Meda’s acquisition of Rottapharm helps both companies fulfil long-held ambitions. The Swedish ...

When two years ago the US FDA’s priority review voucher scheme was extended to include rare ...

The queue-jumping manoeuvre executed yesterday by Sanofi and Regeneron Pharmaceuticals to ...

MedTech

EventAnalyzer

Latest
 

Therapeutic Focus

Market Moving Events

EP Vantage Interviews